3-iodobenzylguanidine has been researched along with doxazosin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biondi, B; Fazio, S; Lombardi, G; Pagano, L; Palmieri, EA; Pulcrano, M; Rossi, A; Tauchmanova, L | 1 |
| Díez, JJ; Fajardo, C; García-Sancho, P; Guerrero-Pérez, F; Iglesias, P; Marengo, AP; Pian, H; Santacruz, E; Villabona, C | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and doxazosin
| Article | Year |
|---|---|
Long-term efficacy of doxazosin plus atenolol in the management of severe and sustained arterial hypertension and reversibility of the cardiac damage induced by chronic cathecolamine excess. A case report in a young girl with recurrent, functioning paraga
Topics: 3-Iodobenzylguanidine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Catecholamines; Child; Doxazosin; Drug Therapy, Combination; Electrocardiography; Female; Heart Diseases; Heart Neoplasms; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Para-Aortic Bodies; Paraganglioma; Radionuclide Imaging; Radiopharmaceuticals | 2004 |
Pheochromocytoma: A three-decade clinical experience in a multicenter study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Catecholamines; Conversion to Open Surgery; Doxazosin; Female; Humans; Hypertension; Male; Metanephrine; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Pancreatic Neoplasms; Phenoxybenzamine; Pheochromocytoma; Postoperative Complications; Retrospective Studies; Time Factors; Tumor Burden; Young Adult | 2021 |